May 13, 2026 CoC LNL Updated Management of Schizophrenia: A Focus on Long-Acting Injectable Therapy (Pharmacists)

The Premier Continuum of Care Lunch N' Learn (LNL) May 13, 2026 CE webinar will be held from 1 - 2 pm ET. We are pleased to provide one (1) 60-minute knowledge-based, ACPE-accredited CE activity to pharmacists and pharmacy technicians.
Updated Management of Schizophrenia: A Focus on Long-Acting Injectable Therapy
SPEAKER: Kristin Waters, PharmD, BCPS, BCPP, Associate Clinical Professor, Department of Pharmacy Practice, University of Connecticut, Storrs, CT
ACPE Universal Activity Number: 0122-0000-26-032-L01-P [0.1 CEU] [1 Contact Hr.]
Date: May 13, 2026 01:00 PM - 02:00 PM
Fee
CE Hours
CE Units
Registration closes on May 13, 2026 01:10 PM
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
Accreditation(s)
Requirements for CE Credit
Support
Wed, May 13, 2026
Objectives
- Identify where long-acting injectable (LAI) antipsychotics fit into treatment guidelines in the management of schizophrenia
- Explain the potential impact of LAI antipsychotics on patient outcomes
- Describe different LAI medications currently available for the treatment of schizophrenia
Speaker(s)/Author(s)
|
Kristin Waters,PharmD, BCPS, BCPP
|
